HHV-8/KSHV-negative and CD20-positive primary effusion lymphoma successfully treated by pleural drainage followed by chemotherapy containing rituximab

Yasushi Terasaki, Hirokazu Okumura, Katsuhiko Saito, Yasuharu Sato, Tadashi Yoshino, Ryo Ichonohasama, Youichi Ishida

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The present patient was diagnosed as having human herpes virus-8 (HHV-8)/ Kaposi sarcoma herpes virus (KSHV)-negative and CD20-positive primary effusion lymphoma (PEL) of the right-sided pleural effusion. After pleural drainage, malignant cells disappeared spontaneously in a small amount of the remaining pleural effusion without chemotherapy. The patient was treated with six cycles of chemotherapy consisting of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. He has been in complete remission for more than 22 months. It is suggested that effusion drainage followed by chemotherapy containing rituximab is a potential treatment strategy for patients with HHV-8/KSHV-negative and CD20-positive PEL.

Original languageEnglish
Pages (from-to)2175-2178
Number of pages4
JournalInternal Medicine
Volume47
Issue number24
DOIs
Publication statusPublished - 2008

Fingerprint

Primary Effusion Lymphoma
Kaposi's Sarcoma
Drainage
Viruses
Drug Therapy
Pleural Effusion
Vincristine
Prednisone
Doxorubicin
Cyclophosphamide
Rituximab

Keywords

  • Pleural effusion drainage
  • Primary effusion lymphoma
  • Rituximab

ASJC Scopus subject areas

  • Internal Medicine

Cite this

HHV-8/KSHV-negative and CD20-positive primary effusion lymphoma successfully treated by pleural drainage followed by chemotherapy containing rituximab. / Terasaki, Yasushi; Okumura, Hirokazu; Saito, Katsuhiko; Sato, Yasuharu; Yoshino, Tadashi; Ichonohasama, Ryo; Ishida, Youichi.

In: Internal Medicine, Vol. 47, No. 24, 2008, p. 2175-2178.

Research output: Contribution to journalArticle

Terasaki, Yasushi ; Okumura, Hirokazu ; Saito, Katsuhiko ; Sato, Yasuharu ; Yoshino, Tadashi ; Ichonohasama, Ryo ; Ishida, Youichi. / HHV-8/KSHV-negative and CD20-positive primary effusion lymphoma successfully treated by pleural drainage followed by chemotherapy containing rituximab. In: Internal Medicine. 2008 ; Vol. 47, No. 24. pp. 2175-2178.
@article{b35d52f937464fd09d8e5075ddb2a168,
title = "HHV-8/KSHV-negative and CD20-positive primary effusion lymphoma successfully treated by pleural drainage followed by chemotherapy containing rituximab",
abstract = "The present patient was diagnosed as having human herpes virus-8 (HHV-8)/ Kaposi sarcoma herpes virus (KSHV)-negative and CD20-positive primary effusion lymphoma (PEL) of the right-sided pleural effusion. After pleural drainage, malignant cells disappeared spontaneously in a small amount of the remaining pleural effusion without chemotherapy. The patient was treated with six cycles of chemotherapy consisting of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. He has been in complete remission for more than 22 months. It is suggested that effusion drainage followed by chemotherapy containing rituximab is a potential treatment strategy for patients with HHV-8/KSHV-negative and CD20-positive PEL.",
keywords = "Pleural effusion drainage, Primary effusion lymphoma, Rituximab",
author = "Yasushi Terasaki and Hirokazu Okumura and Katsuhiko Saito and Yasuharu Sato and Tadashi Yoshino and Ryo Ichonohasama and Youichi Ishida",
year = "2008",
doi = "10.2169/internalmedicine.47.1565",
language = "English",
volume = "47",
pages = "2175--2178",
journal = "Internal Medicine",
issn = "0918-2918",
publisher = "Japanese Society of Internal Medicine",
number = "24",

}

TY - JOUR

T1 - HHV-8/KSHV-negative and CD20-positive primary effusion lymphoma successfully treated by pleural drainage followed by chemotherapy containing rituximab

AU - Terasaki, Yasushi

AU - Okumura, Hirokazu

AU - Saito, Katsuhiko

AU - Sato, Yasuharu

AU - Yoshino, Tadashi

AU - Ichonohasama, Ryo

AU - Ishida, Youichi

PY - 2008

Y1 - 2008

N2 - The present patient was diagnosed as having human herpes virus-8 (HHV-8)/ Kaposi sarcoma herpes virus (KSHV)-negative and CD20-positive primary effusion lymphoma (PEL) of the right-sided pleural effusion. After pleural drainage, malignant cells disappeared spontaneously in a small amount of the remaining pleural effusion without chemotherapy. The patient was treated with six cycles of chemotherapy consisting of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. He has been in complete remission for more than 22 months. It is suggested that effusion drainage followed by chemotherapy containing rituximab is a potential treatment strategy for patients with HHV-8/KSHV-negative and CD20-positive PEL.

AB - The present patient was diagnosed as having human herpes virus-8 (HHV-8)/ Kaposi sarcoma herpes virus (KSHV)-negative and CD20-positive primary effusion lymphoma (PEL) of the right-sided pleural effusion. After pleural drainage, malignant cells disappeared spontaneously in a small amount of the remaining pleural effusion without chemotherapy. The patient was treated with six cycles of chemotherapy consisting of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. He has been in complete remission for more than 22 months. It is suggested that effusion drainage followed by chemotherapy containing rituximab is a potential treatment strategy for patients with HHV-8/KSHV-negative and CD20-positive PEL.

KW - Pleural effusion drainage

KW - Primary effusion lymphoma

KW - Rituximab

UR - http://www.scopus.com/inward/record.url?scp=61749103969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61749103969&partnerID=8YFLogxK

U2 - 10.2169/internalmedicine.47.1565

DO - 10.2169/internalmedicine.47.1565

M3 - Article

VL - 47

SP - 2175

EP - 2178

JO - Internal Medicine

JF - Internal Medicine

SN - 0918-2918

IS - 24

ER -